MCK:NYE-McKesson Corporation (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 579.74

Change

0.00 (0.00)%

Market Cap

USD 31.54B

Volume

2.06M

Analyst Target

USD 185.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. Its segments include McKesson Distribution Solutions and McKesson Technology Solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-22 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

-0.05 (-0.02%)

USD 44.01B
CAH Cardinal Health Inc

+0.07 (+0.06%)

USD 28.62B
NVG Nuveen AMT Free Municipal Cred..

-0.05 (-0.41%)

N/A
OMI Owens & Minor Inc

+0.04 (+0.32%)

N/A

ETFs Containing MCK

FHI:CA CI Health Care Giants Cov.. 6.48 % 0.75 %

-0.15 (0.25%)

CAD 0.08B
XYLP:LSE Global X S&P 500® Covere.. 4.10 % 0.00 %

+0.16 (+0.25%)

N/A
XGSD:XETRA Xtrackers Stoxx Global Se.. 3.45 % 0.00 %

-0.01 (0.25%)

N/A
WHCS:SW iShares MSCI World Health.. 3.15 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 3.08 % 0.00 %

+0.04 (+0.25%)

N/A
SHRY First Trust Bloomberg Sha.. 2.93 % 0.00 %

+0.10 (+0.25%)

USD 0.02B
BUSA 2.71 % 0.00 %

N/A

N/A
XHS SPDR® S&P Health Care Se.. 2.43 % 0.35 %

-0.09 (0.25%)

USD 0.07B
POWA Invesco Bloomberg Pricing.. 2.11 % 0.00 %

-0.68 (0.25%)

N/A
BMVP Invesco Bloomberg MVP Mul.. 2.11 % 0.00 %

-0.12 (0.25%)

N/A
RSPH Invesco S&P 500 Equal Wei.. 2.00 % 0.00 %

+0.04 (+0.25%)

USD 0.88B
GQI Natixis ETF Trust 1.88 % 0.00 %

+0.35 (+0.25%)

USD 0.14B
XLVE:CA 1.73 % 0.00 %

N/A

N/A
MVEW:SW iShares Edge MSCI World M.. 1.47 % 0.00 %

N/A

USD 0.53B
MVWE:SW iShares Edge MSCI World M.. 1.47 % 0.00 %

N/A

USD 0.07B
MVEW:LSE iShares Edge MSCI World M.. 1.46 % 0.00 %

-0.01 (0.25%)

USD 0.54B
XDEB:F db x-trackers MSCI World .. 1.36 % 0.00 %

-0.13 (0.25%)

USD 0.92B
XDEB:XETRA db x-trackers MSCI World .. 1.36 % 0.00 %

-0.23 (0.25%)

USD 0.42B
SXR0:F iShares VI Public Limited.. 1.35 % 0.00 %

-0.03 (0.25%)

USD 0.17B
SXR0:XETRA iShares Edge MSCI World M.. 1.35 % 0.00 %

-0.05 (0.25%)

USD 0.09B
UEEH:XETRA iShares Edge MSCI World M.. 1.35 % 0.00 %

-0.03 (0.25%)

USD 0.03B
MVOL:SW iShares Edge MSCI World M.. 1.35 % 0.00 %

+0.44 (+0.25%)

USD 2.87B
WMVG:LSE iShares Edge MSCI World M.. 1.34 % 0.00 %

-0.04 (0.25%)

USD 0.06B
IQQ0:XETRA iShares Edge MSCI World M.. 1.32 % 0.00 %

-0.39 (0.25%)

USD 3.63B
DEUS Xtrackers Russell US Mult.. 1.14 % 0.18 %

+0.10 (+0.25%)

USD 0.20B
DEF 0.00 % 0.59 %

N/A

N/A
EZY 0.00 % 0.38 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

-0.19 (0.25%)

N/A
PPH VanEck Pharmaceutical ETF 0.00 % 0.36 %

+1.26 (+0.25%)

USD 0.61B
EQRR ProShares Equities for Ri.. 0.00 % 0.35 %

-0.08 (0.25%)

USD 0.01B
CLRG 0.00 % 0.25 %

N/A

N/A
BVNSC 0.00 % 0.00 %

N/A

N/A
FHI-B:CA CI Health Care Giants Cov.. 0.00 % 0.00 %

N/A

CAD 0.05B
RTH VanEck Retail ETF 0.00 % 0.35 %

-2.01 (0.25%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
SPYB Tradr 2X Long SPY Weekly .. 0.00 % 0.35 %

+0.41 (+0.25%)

N/A
SYV 0.00 % 0.60 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

-10.50 (0.25%)

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.46 (0.25%)

N/A
XDEB:LSE Xtrackers MSCI World Mini.. 0.00 % 0.00 %

-4.50 (0.25%)

N/A
IQQ0:F iShares Edge MSCI World M.. 0.00 % 0.00 %

-0.21 (0.25%)

N/A
CBUF:XETRA iShares MSCI World Health.. 0.00 % 0.00 %

-0.04 (0.25%)

USD 1.13B
CFCV 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 25.22% 100% F 83% B
Dividend Return 0.57% 25% F 7% C-
Total Return 25.79% 100% F 82% B
Trailing 12 Months  
Capital Gain 27.64% 100% F 85% B
Dividend Return 0.59% 25% F 6% D-
Total Return 28.23% 100% F 84% B
Trailing 5 Years  
Capital Gain 317.65% 100% F 97% N/A
Dividend Return 7.82% 40% F 22% F
Total Return 325.47% 100% F 97% N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.67% 80% B- 91% A-
Dividend Return 39.55% 80% B- 90% A-
Total Return 0.87% 40% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 19.40% 80% B- 56% F
Risk Adjusted Return 203.87% 100% F 100% F
Market Capitalization 31.54B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 16.90 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.